Cargando…
A universal neocortical mask for Centiloid quantification
INTRODUCTION: The Centiloid (CL) project was developed to harmonize the quantification of amyloid beta (Aβ) positron emission tomography (PET) scans to a unified scale. The CL neocortical mask was defined using (11)C Pittsburgh compound B (PiB), overlooking potential differences in regional distribu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363815/ https://www.ncbi.nlm.nih.gov/pubmed/37492802 http://dx.doi.org/10.1002/dad2.12457 |
_version_ | 1785076716168806400 |
---|---|
author | Bourgeat, Pierrick Doré, Vincent Rowe, Christopher C. Benzinger, Tammie Tosun, Duygu Goyal, Manu S. LaMontagne, Pamela Jin, Liang Weiner, Michael W. Masters, Colin L. Fripp, Jurgen Villemagne, Victor L. |
author_facet | Bourgeat, Pierrick Doré, Vincent Rowe, Christopher C. Benzinger, Tammie Tosun, Duygu Goyal, Manu S. LaMontagne, Pamela Jin, Liang Weiner, Michael W. Masters, Colin L. Fripp, Jurgen Villemagne, Victor L. |
author_sort | Bourgeat, Pierrick |
collection | PubMed |
description | INTRODUCTION: The Centiloid (CL) project was developed to harmonize the quantification of amyloid beta (Aβ) positron emission tomography (PET) scans to a unified scale. The CL neocortical mask was defined using (11)C Pittsburgh compound B (PiB), overlooking potential differences in regional distribution among Aβ tracers. We created a universal mask using an independent dataset of five Aβ tracers, and investigated its impact on inter‐tracer agreement, tracer variability, and group separation. METHODS: Using data from the Alzheimer's Dementia Onset and Progression in International Cohorts (ADOPIC) study (Australian Imaging Biomarkers and Lifestyle + Alzheimer's Disease Neuroimaging Initiative + Open Access Series of Imaging Studies), age‐matched pairs of mild Alzheimer's disease (AD) and healthy controls (HC) were selected: (18)F‐florbetapir (N = 147 pairs), (18)F‐florbetaben (N = 22), (18)F‐flutemetamol (N = 10), (18)F‐NAV (N = 42), (11)C‐PiB (N = 63). The images were spatially and standardized uptake value ratio normalized. For each tracer, the mean AD–HC difference image was thresholded to maximize the overlap with the standard neocortical mask. The universal mask was defined as the intersection of all five masks. It was evaluated on the Global Alzheimer's Association Interactive Network (GAAIN) head‐to‐head datasets in terms of inter‐tracer agreement and variance in the young controls (YC) and on the ADOPIC dataset comparing separation between HC/AD and HC/mild cognitive impairment (MCI). RESULTS: In the GAAIN dataset, the universal mask led to a small reduction in the variance of the YC, and a small increase in the inter‐tracer agreement. In the ADOPIC dataset, it led to a better separation between HC/AD and HC/MCI at baseline. DISCUSSION: The universal CL mask led to an increase in inter‐tracer agreement and group separation. Those increases were, however, very small, and do not provide sufficient benefits to support departing from the existing standard CL mask, which is suitable for the quantification of all Aβ tracers. HIGHLIGHTS: This study built an amyloid universal mask using a matched cohort for the five most commonly used amyloid positron emission tomography tracers. There was a high overlap between each tracer‐specific mask. Differences in quantification and group separation between the standard and universal mask were small. The existing standard Centiloid mask is suitable for the quantification of all amyloid beta tracers. |
format | Online Article Text |
id | pubmed-10363815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103638152023-07-25 A universal neocortical mask for Centiloid quantification Bourgeat, Pierrick Doré, Vincent Rowe, Christopher C. Benzinger, Tammie Tosun, Duygu Goyal, Manu S. LaMontagne, Pamela Jin, Liang Weiner, Michael W. Masters, Colin L. Fripp, Jurgen Villemagne, Victor L. Alzheimers Dement (Amst) Research Articles INTRODUCTION: The Centiloid (CL) project was developed to harmonize the quantification of amyloid beta (Aβ) positron emission tomography (PET) scans to a unified scale. The CL neocortical mask was defined using (11)C Pittsburgh compound B (PiB), overlooking potential differences in regional distribution among Aβ tracers. We created a universal mask using an independent dataset of five Aβ tracers, and investigated its impact on inter‐tracer agreement, tracer variability, and group separation. METHODS: Using data from the Alzheimer's Dementia Onset and Progression in International Cohorts (ADOPIC) study (Australian Imaging Biomarkers and Lifestyle + Alzheimer's Disease Neuroimaging Initiative + Open Access Series of Imaging Studies), age‐matched pairs of mild Alzheimer's disease (AD) and healthy controls (HC) were selected: (18)F‐florbetapir (N = 147 pairs), (18)F‐florbetaben (N = 22), (18)F‐flutemetamol (N = 10), (18)F‐NAV (N = 42), (11)C‐PiB (N = 63). The images were spatially and standardized uptake value ratio normalized. For each tracer, the mean AD–HC difference image was thresholded to maximize the overlap with the standard neocortical mask. The universal mask was defined as the intersection of all five masks. It was evaluated on the Global Alzheimer's Association Interactive Network (GAAIN) head‐to‐head datasets in terms of inter‐tracer agreement and variance in the young controls (YC) and on the ADOPIC dataset comparing separation between HC/AD and HC/mild cognitive impairment (MCI). RESULTS: In the GAAIN dataset, the universal mask led to a small reduction in the variance of the YC, and a small increase in the inter‐tracer agreement. In the ADOPIC dataset, it led to a better separation between HC/AD and HC/MCI at baseline. DISCUSSION: The universal CL mask led to an increase in inter‐tracer agreement and group separation. Those increases were, however, very small, and do not provide sufficient benefits to support departing from the existing standard CL mask, which is suitable for the quantification of all Aβ tracers. HIGHLIGHTS: This study built an amyloid universal mask using a matched cohort for the five most commonly used amyloid positron emission tomography tracers. There was a high overlap between each tracer‐specific mask. Differences in quantification and group separation between the standard and universal mask were small. The existing standard Centiloid mask is suitable for the quantification of all amyloid beta tracers. John Wiley and Sons Inc. 2023-07-21 /pmc/articles/PMC10363815/ /pubmed/37492802 http://dx.doi.org/10.1002/dad2.12457 Text en © 2023 Commonwealth of Australia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Bourgeat, Pierrick Doré, Vincent Rowe, Christopher C. Benzinger, Tammie Tosun, Duygu Goyal, Manu S. LaMontagne, Pamela Jin, Liang Weiner, Michael W. Masters, Colin L. Fripp, Jurgen Villemagne, Victor L. A universal neocortical mask for Centiloid quantification |
title | A universal neocortical mask for Centiloid quantification |
title_full | A universal neocortical mask for Centiloid quantification |
title_fullStr | A universal neocortical mask for Centiloid quantification |
title_full_unstemmed | A universal neocortical mask for Centiloid quantification |
title_short | A universal neocortical mask for Centiloid quantification |
title_sort | universal neocortical mask for centiloid quantification |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363815/ https://www.ncbi.nlm.nih.gov/pubmed/37492802 http://dx.doi.org/10.1002/dad2.12457 |
work_keys_str_mv | AT bourgeatpierrick auniversalneocorticalmaskforcentiloidquantification AT dorevincent auniversalneocorticalmaskforcentiloidquantification AT rowechristopherc auniversalneocorticalmaskforcentiloidquantification AT benzingertammie auniversalneocorticalmaskforcentiloidquantification AT tosunduygu auniversalneocorticalmaskforcentiloidquantification AT goyalmanus auniversalneocorticalmaskforcentiloidquantification AT lamontagnepamela auniversalneocorticalmaskforcentiloidquantification AT jinliang auniversalneocorticalmaskforcentiloidquantification AT weinermichaelw auniversalneocorticalmaskforcentiloidquantification AT masterscolinl auniversalneocorticalmaskforcentiloidquantification AT frippjurgen auniversalneocorticalmaskforcentiloidquantification AT villemagnevictorl auniversalneocorticalmaskforcentiloidquantification AT auniversalneocorticalmaskforcentiloidquantification AT auniversalneocorticalmaskforcentiloidquantification AT bourgeatpierrick universalneocorticalmaskforcentiloidquantification AT dorevincent universalneocorticalmaskforcentiloidquantification AT rowechristopherc universalneocorticalmaskforcentiloidquantification AT benzingertammie universalneocorticalmaskforcentiloidquantification AT tosunduygu universalneocorticalmaskforcentiloidquantification AT goyalmanus universalneocorticalmaskforcentiloidquantification AT lamontagnepamela universalneocorticalmaskforcentiloidquantification AT jinliang universalneocorticalmaskforcentiloidquantification AT weinermichaelw universalneocorticalmaskforcentiloidquantification AT masterscolinl universalneocorticalmaskforcentiloidquantification AT frippjurgen universalneocorticalmaskforcentiloidquantification AT villemagnevictorl universalneocorticalmaskforcentiloidquantification AT universalneocorticalmaskforcentiloidquantification AT universalneocorticalmaskforcentiloidquantification |